Furthermore, cells (such as umbilical cord mesenchymal stem cells and tonsil/bone mesenchymal stem cells) expressing PD-L1, which has the potential to inhibit lymphocyte proliferation, exhibited reduced immunogenicity and improved immunosuppressive capacity, which have been reported to lead to effective immunotherapy for diseases such as psoriasis (97). Here, CD274 is linked to psoriasis.